Nulojix (belatacept) - BMS
When End-Stage Isn't Final: Late Renal Recovery After Prolonged Dialysis Dependence (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #FR-PO1015; Pres time: Oct 23, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "Immunosuppression was then transitioned to belatacept...Withdrawal of the offending agent can lead to partial or complete improvement in kidney function, particularly when nephrotoxicity is identified early. This case highlights the importance of continued monitoring of residual kidney function even in long-term dialysis patients." 
Acute Kidney Injury • Chronic Kidney Disease • Fibrosis • Immunology • Infectious Disease • Nephrology • Pneumonia • Renal Disease • Respiratory Diseases
https://www.asn-online.org/education/kidneyweek/2026/program-abstract.aspx?controlId=4558784
 
Keerthana Gangadharan; Khushboo Lakhatariya; Vinay Krishna Pulusu; Emily Simoneau; Jyotsana Thakkar
 
Oct 2, 2026
 
Prev Next